+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fujirebio Diagnostics Inc - logo

Fujirebio Diagnostics manufactures and supplies in vitro diagnostics and biomarkers. Fujirebio Diagnostics specializes in the manufacturing of manual assay products, reagents and controls distributed throughout the U.S. and around the world, as well as custom-developed products for use through our worldwide network of distribution partners. The company was founded in 1979 and is based in Malvern, Pennsylvania with manufacturing facilities in Malvern, Pennsylvania; Seguin, Texas; and Goteborg, Sweden.

Hepatitis Diagnostic Test Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 - Product Thumbnail Image

Hepatitis Diagnostic Test Market - Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

  • Report
  • October 2023
  • 177 Pages
  • Global
From
Hepatitis Diagnostic Tests Global Market Report 2024 - Product Thumbnail Image

Hepatitis Diagnostic Tests Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Hospital Acquired Infections Testing Kits Global Market Report 2024 - Product Thumbnail Image

Hospital Acquired Infections Testing Kits Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Rabies Diagnostics Global Market Report 2024 - Product Thumbnail Image

Rabies Diagnostics Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Immunoassay Market - Forecasts from 2024 to 2029 - Product Thumbnail Image

Immunoassay Market - Forecasts from 2024 to 2029

  • Report
  • April 2024
  • 124 Pages
  • Global
From
2024 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Japan Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 410 Pages
  • Japan
From
2024 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Europe Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: France, Germany, Italy, Spain, UK - Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 495 Pages
  • Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From
2024 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 France Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 407 Pages
  • France
From
2024 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Germany Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 407 Pages
  • Germany
From
2024 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Italy Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 402 Pages
  • Italy
From
2024 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 407 Pages
  • Spain
From
2024 UK Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 UK Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 408 Pages
  • United Kingdom
From
2024 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 U.S. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Supplier Shares by Country and Segment Forecasts, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 430 Pages
  • United States
From
2024 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: US, Europe, Japan - Supplier Shares and Segment Forecasts by Country, Emerging Technologies, Competitive Strategies - Product Thumbnail Image

2024 Global Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: US, Europe, Japan - Supplier Shares and Segment Forecasts by Country, Emerging Technologies, Competitive Strategies

  • Report
  • August 2024
  • 570 Pages
  • Global, Europe, United States, ... Global, Europe, United States, Japan
From
2024 Costa Rica Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 Costa Rica Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • Costa Rica
From
2024 Colombia Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 Colombia Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • Colombia
From
2024 China Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 China Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • China
From
2024 Chile Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 Chile Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • Chile
From
2024 Canada Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 Canada Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • Canada
From
2024 Bulgaria Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks - Product Thumbnail Image

2024 Bulgaria Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities--2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks

  • Report
  • June 2024
  • Bulgaria
From
Loading Indicator